Latest headcount
59,000
YoY change
+11.3%
Headcount CAGR
+6.5%
Revenue / employee
$340K
Employee count history for Boston Scientific
| Fiscal year | Employees |
|---|---|
| 1996 | 9,580 |
| 1997 | 11,000 |
| 1998 | 14,000 |
| 2000 | 13,720 |
| 2001 | 14,400 |
| 2002 | 13,900 |
| 2003 | 15,000 |
| 2004 | 17,500 |
| 2005 | 19,800 |
| 2006 | 28,600 |
| 2007 | 27,500 |
| 2008 | 24,800 |
| 2009 | 26,000 |
| 2010 | 25,000 |
| 2011 | 24,000 |
| 2012 | 24,000 |
| 2013 | 23,000 |
| 2014 | 24,000 |
| 2015 | 25,000 |
| 2016 | 27,000 |
| 2017 | 29,000 |
| 2018 | 32,000 |
| 2019 | 36,000 |
| 2020 | 38,000 |
| 2021 | 41,000 |
| 2022 | 45,000 |
| 2023 | 48,000 |
| 2024 | 53,000 |
| 2025 | 59,000 |
Revenue per employee for Boston Scientific
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 1996 | $153K |
| 1997 | $170K |
| 1998 | $160K |
| 2000 | $194K |
| 2001 | $186K |
| 2002 | $210K |
| 2003 | $232K |
| 2004 | $321K |
| 2005 | $317K |
| 2006 | $273K |
| 2007 | $304K |
| 2008 | $325K |
| 2009 | $315K |
| 2010 | $312K |
| 2011 | $318K |
| 2012 | $302K |
| 2013 | $311K |
| 2014 | $308K |
| 2015 | $299K |
| 2016 | $311K |
| 2017 | $312K |
| 2018 | $307K |
| 2019 | $298K |
| 2020 | $261K |
| 2021 | $290K |
| 2022 | $282K |
| 2023 | $297K |
| 2024 | $316K |
| 2025 | $340K |
Earnings per employee for Boston Scientific
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 1996 | $17.4K |
| 1997 | $12.7K |
| 1998 | -$18.9K |
| 2000 | $27.2K |
| 2001 | -$3.75K |
| 2002 | $26.8K |
| 2003 | $31.5K |
| 2004 | $60.7K |
| 2005 | $31.7K |
| 2006 | -$125K |
| 2007 | -$18K |
| 2008 | -$82.1K |
| 2009 | -$39.4K |
| 2010 | -$42.6K |
| 2011 | $18.4K |
| 2012 | -$170K |
| 2013 | -$5.26K |
| 2014 | -$4.96K |
| 2015 | -$9.56K |
| 2016 | $12.9K |
| 2017 | $3.59K |
| 2018 | $52.2K |
| 2019 | $131K |
| 2020 | -$2.16K |
| 2021 | $25.4K |
| 2022 | $15.5K |
| 2023 | $33.2K |
| 2024 | $35K |
| 2025 | $48.9K |
Employee count history for Boston Scientific (BSX)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 202559,000+11.3%
- 202453,000+10.4%
- 202348,000+6.7%
- 202245,000+9.8%
- 202141,000+7.9%
- 202038,000+5.6%
- 201936,000+12.5%
- 201832,000+10.3%
- 201729,000+7.4%
- 201627,000+8.0%
- 201525,000+4.2%
- 201424,000+4.3%
- 201323,000-4.2%
- 201224,0000.0%
- 201124,000-4.0%
- 201025,000-3.8%
- 200926,000+4.8%
- 200824,800-9.8%
- 200727,500-3.8%
- 200628,600+44.4%
- 200519,800+13.1%
- 200417,500+16.7%
- 200315,000+7.9%
- 200213,900-3.5%
- 200114,400+5.0%
- 200013,720—
- 199912,615—
- 199814,000+27.3%
- 199711,000+14.8%
- 19969,580—
About Boston Scientific's employee count
Boston Scientific (BSX) employed 59,000 people in fiscal year 2025, based on its most recent annual report. That headcount grew by +6,000 (+11.3%) from 53,000 a year earlier.
Across the 1996–2025 period, the company's reported workforce went from 9,580 to 59,000 employees — a compound annual growth rate (CAGR) of +6.5% per year.
Boston Scientific generated about $340K of revenue and $48.9K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on BSX
Employees — 10 rounds, every one of them BSX against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.